Neuroendocrine Tumors
Conditions
Keywords
neuroendocrine tumor
Brief summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is at least 18 years of age * Diagnosis of neuroendocrine tumor * Ability to understand and the willingness to sign a written informed consent document
Exclusion criteria
* Enrolled in another research study * Patients with psychiatric illness/social situations that would limit compliance with study requirements * Pregnant or lactating woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to join in a neuroendocrine tumor clinical research | 3 months |
| Number of neuroendocrine tumor patients who remain in clinical trial until completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed